ATXN3 and Spinocerebellar ataxia type 3: Carbamazepine (CBZ), which is a medicine used for the treatment of epilepsy, nerve pain, and bipolar disorder, was investigated as a therapeutic option for MJD/SCA3 through autophagy activation.